Covalent inhibitors in Parkinson's disease: Molecular targeting strategies for neuroprotective intervention
{{output}}
Parkinson's disease (PD) is a complex neurodegenerative disorder characterized by dopaminergic neuronal loss, protein aggregation, and neuroinflammation. Current symptomatic therapies have not demonstrated disease-modifying effects. Covalent inhibitors repres... ...